INOVOTION visit

-

INOVOTION is a biotech company (spin-off from Grenoble-Alpes University) which developed a unique in vivo technology dedicated to efficacy and toxicity evaluations for oncology and immuno-oncology treatments. 

This unique platform provides early analysis of drug candidates from small molecules to 
biologics, before the classical preclinical stage. By eliminating low-value molecules early, 
INOVOTION accelerates the drug discovery process, increases the R&D productivity, and 
reduces its costs.  

INOVOTION built this xenograft model using chicken embryo because it has tremendous 
benefits: fast, robust, affordable, and predictive. These in vivo assays will save time and give 
a clear competitive advantage to public and private researchers.  

This next generation of in vivo efficacy and toxicity tests covers fours main aspects:  
- Efficacy assays for anti-cancer treatments including antibodies and immune-checkpoints  
- Early Toxicity assays for drug candidates  
- Target Validation in oncology  
- Multi-Cancer Screening to (re)positioning a treatment  

INOVOTION has been invited by prof.dr. Ronit Shiri-Sverdlov as part of the monthly Scientific Meeting with Division II within NUTRIM. 

Relevant links

Website: INOVOTION

Also read

  • Global Privacy Officer Certification (ECPC-G)

    This is a specialised eight-weeks, online, hands-on training focused on privacy risk management enabling participants to acquire the “must know knowledge”, the “do’s and don’ts” and most effective methodology to act as Global Data Protection Officer.

    5 May
    5 Jul
  • Graduation Ceremonies Masters

    We are proud to hand the diploma's to our graduates on this festive day. 
    The graduates will receive an invitation from Law Events Office to register. 

    27 Jun
    28 Nov